المؤلفون: Al-Jamaei AAH; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Amsterdam, The Netherlands.; Department of Oral Medicine, Periodontics, Diagnostic, and Oral Radiology, Faculty of Dentistry, Sanaá University, Sanaá, Yemen.; Department of Oral Surgery and Oral Medicine, Al-Razi University, Sanaá, Yemen., Epstein JB; Cedars-Sinai Medical Center, Los Angeles, CA, USA.; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., de Visscher JGAM; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Amsterdam, The Netherlands., Spielberger RT; Department of BMT, Southern California Permanente Medical Group, Kaiser Permanente, Los Angeles, CA, USA.; Department of Hematology &, Center for Stem Cell Transplantation at City of Hope Comprehensive Cancer Center, Hematopoietic Cell Transplantation, Duarte, CA, USA., Nakamura R; Department of Hematology &, Center for Stem Cell Transplantation at City of Hope Comprehensive Cancer Center, Hematopoietic Cell Transplantation, Duarte, CA, USA., Raber-Durlacher JE; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, Amsterdam, The Netherlands. j.raber.durlacher@acta.nl.; Department of Oral Medicine, Academic Centre for Dentistry Amsterdam, Amsterdam, The Netherlands. j.raber.durlacher@acta.nl.

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jul 17; Vol. 32 (8), pp. 519. Date of Electronic Publication: 2024 Jul 17.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Comparative Study; Review

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/etiology , Stomatitis*/etiology , Stomatitis*/prevention & control , Methotrexate*/administration & dosage , Methotrexate*/therapeutic use , Methotrexate*/adverse effects , Immunosuppressive Agents*/administration & dosage , Immunosuppressive Agents*/adverse effects, Humans ; Randomized Controlled Trials as Topic ; Severity of Illness Index

المؤلفون: Manni A; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy. Electronic address: alessia.manni@uniba.it., Oggiano F; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy. Electronic address: federica.oggiano@uniba.it., Palazzo C; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy. Electronic address: claudia.palazzo@uniba.it., Panetta V; L'altrastatistica srl -Consultancy & Training- Biostatistics office, Rome, Cap 00174, Italy. Electronic address: valentina.panetta@laltrastatistica.com., Gargano CD; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy. Electronic address: concetta.gargano@uniba.it., Mangialardi V; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy., Guerra T; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy., Iaffaldano A; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy., Caputo F; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy., Iaffaldano P; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy. Electronic address: pietro.iaffaldano@uniba.it., Ruggieri M; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy. Electronic address: maddalena.ruggieri@uniba.it., Trojano M; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy. Electronic address: maria.trojano@uniba.it., Paolicelli D; Department of Translational Biomedicine and Neurosciences (DiBraiN), University of Bari Aldo Moro, Bari, Italy. Electronic address: damiano.paolicelli@uniba.it.

المصدر: Journal of the neurological sciences [J Neurol Sci] 2024 Jul 15; Vol. 462, pp. 123070. Date of Electronic Publication: 2024 May 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5883 (Electronic) Linking ISSN: 0022510X NLM ISO Abbreviation: J Neurol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Cladribine*/therapeutic use , Cladribine*/administration & dosage , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/administration & dosage, Humans ; Female ; Male ; Adult ; Middle Aged ; Treatment Outcome ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/blood ; Follow-Up Studies ; Multiple Sclerosis/drug therapy ; Multiple Sclerosis/blood

المؤلفون: Satake Y; Department of Internal Medicine, Nagaoka Red Cross Hospital, Niigata, Japan., Sakai S; Department of Internal Medicine, Nagaoka Red Cross Hospital, Niigata, Japan., Takao T; Department of Neurosurgery, Nagaoka Red Cross Hospital, Niigata, Japan., Saeki T; Department of Internal Medicine, Nagaoka Red Cross Hospital, Niigata, Japan.

المصدر: Modern rheumatology case reports [Mod Rheumatol Case Rep] 2024 Jul 08; Vol. 8 (2), pp. 310-313.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101761026 Publication Model: Print Cited Medium: Internet ISSN: 2472-5625 (Electronic) Linking ISSN: 24725625 NLM ISO Abbreviation: Mod Rheumatol Case Rep Subsets: MEDLINE

مواضيع طبية MeSH: Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Subarachnoid Hemorrhage*/etiology , Subarachnoid Hemorrhage*/diagnosis , Subarachnoid Hemorrhage*/complications , Subarachnoid Hemorrhage*/drug therapy , Glucocorticoids*/therapeutic use , Glucocorticoids*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Antineutrophil Cytoplasmic*/immunology , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/administration & dosage, Humans ; Treatment Outcome ; Churg-Strauss Syndrome/diagnosis ; Churg-Strauss Syndrome/complications ; Churg-Strauss Syndrome/drug therapy ; Peroxidase/immunology ; Granulomatosis with Polyangiitis/drug therapy ; Granulomatosis with Polyangiitis/diagnosis ; Granulomatosis with Polyangiitis/complications ; Male ; Drug Therapy, Combination ; Middle Aged ; Female

المؤلفون: Fukumoto K; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.; Department of Medical Education and General Practice, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Watanabe R; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Tsutsumi M; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Takakuwa T; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Miyamoto M; Department of Internal Medicine, Ohno Memorial Hospital, Osaka, Japan., Hayashi N; Department of Internal Medicine, Ohno Memorial Hospital, Osaka, Japan., Yamada S; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Furumitsu Y; Department of Internal Medicine, Ohno Memorial Hospital, Osaka, Japan., Hino M; Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Hashimoto M; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

المصدر: Modern rheumatology case reports [Mod Rheumatol Case Rep] 2024 Jul 08; Vol. 8 (2), pp. 243-248.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101761026 Publication Model: Print Cited Medium: Internet ISSN: 2472-5625 (Electronic) Linking ISSN: 24725625 NLM ISO Abbreviation: Mod Rheumatol Case Rep Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid*/drug therapy , Arthritis, Rheumatoid*/complications , Arthritis, Rheumatoid*/diagnosis , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/adverse effects , Immunosuppressive Agents*/administration & dosage, Humans ; Female ; Aged ; Lymphoproliferative Disorders/etiology ; Lymphoproliferative Disorders/diagnosis ; Lymphoproliferative Disorders/drug therapy ; Epstein-Barr Virus Infections/complications ; Epstein-Barr Virus Infections/diagnosis ; Epstein-Barr Virus Infections/drug therapy ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Large B-Cell, Diffuse/diagnosis ; Lymphoma, Large B-Cell, Diffuse/complications ; Antirheumatic Agents/therapeutic use ; Antirheumatic Agents/adverse effects ; Antirheumatic Agents/administration & dosage ; Treatment Outcome ; Remission Induction ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Sofue H; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kida T; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Hirano A; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Omura S; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kadoya M; Center for Rheumatic Disease, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, Japan., Nakagomi D; Department of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan., Abe Y; Department of Internal Medicine and Rheumatology, Juntendo University, Tokyo, Japan., Takizawa N; Department of Rheumatology, Chubu Rosai Hospital, Nagoya, Japan., Nomura A; Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan., Kukida Y; Department of Rheumatology, Japanese Red Cross Society Kyoto Daini Hospital, Kyoto, Japan., Kondo N; Department of Nephrology, Kyoto Katsura Hospital, Kyoto, Japan., Yamano Y; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, Japan., Yanagida T; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan., Endo K; Department of General Internal Medicine, Tottori Prefectural Central Hospital, Tottori, Japan., Hirata S; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan., Matsui K; Department of Diabetes, Endocrinology and Clinical Immunology, Hyogo Medical University School of Medicine, Hyogo, Japan., Takeuchi T; Department of Internal Medicine (IV), Osaka Medical and Pharmaceutical University, Osaka, Japan., Ichinose K; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Rheumatology, Shimane University Faculty of Medicine, Shimane, Japan., Kato M; Department of Rheumatology, Endocrinology and Nephrology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan., Yanai R; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan., Matsuo Y; Department of Rheumatology, Tokyo Kyosai Hospital, Tokyo, Japan.; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Shimojima Y; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan., Nishioka R; Department of Rheumatology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan., Okazaki R; Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Yonago, Japan., Takata T; Division of Gastroenterology and Nephrology, Tottori University, Yonago, Japan., Ito T; Division of Nephrology, Department of Internal Medicine, Teikyo University Chiba Medical Center, Chiba, Japan., Moriyama M; Department of Rheumatology, Shimane University Faculty of Medicine, Shimane, Japan., Takatani A; Rheumatic Disease Center, Sasebo Chuo Hospital, Nagasaki, Japan., Miyawaki Y; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Ito-Ihara T; The Clinical and Translational Research Center, University Hospital, Kyoto Prefectural University of Medicine, Kyoto, Japan., Yajima N; Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.; Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan.; Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima, Japan., Kawaguchi T; Department of Practical Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Fujioka K; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Fujii W; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Seno T; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Wada M; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kohno M; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Kawahito Y; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

المصدر: Modern rheumatology [Mod Rheumatol] 2024 Jul 06; Vol. 34 (4), pp. 767-774.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN: 1439-7609 (Electronic) Linking ISSN: 14397595 NLM ISO Abbreviation: Mod Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/drug therapy , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/mortality , Remission Induction* , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/administration & dosage, Humans ; Retrospective Studies ; Female ; Male ; Aged ; Middle Aged ; Administration, Intravenous ; Treatment Outcome ; Aged, 80 and over ; Dose-Response Relationship, Drug

المؤلفون: Oshima N; Inflammatory Bowel Disease Center, Shimane University Hospital, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.; Department of Internal Medicine II, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Hiraoka S; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Hayashi R; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan., Takahashi S; Department of Gastroenterology, Kagawa Prefectural Central Hospital, Kagawa, Japan., Ishii M; General Internal Medicine 2, General Medical Center, Kawasaki Medical School, Okayama, Japan., Hashimoto S; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Yashima K; Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan., Igawa S; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Inokuchi T; Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan., Ueno Y; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan., Inaba T; Department of Gastroenterology, Kagawa Prefectural Central Hospital, Kagawa, Japan., Matsumoto H; Division of Gastroenterology, Kawasaki Medical School, Okayama, Japan., Kawashima K; Inflammatory Bowel Disease Center, Shimane University Hospital, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.; Department of Internal Medicine II, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan., Takami T; Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan., Isomoto H; Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Tottori, Japan., Shiotani A; Division of Gastroenterology, Kawasaki Medical School, Okayama, Japan., Tanaka S; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan., Ishihara S; Inflammatory Bowel Disease Center, Shimane University Hospital, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.; Department of Internal Medicine II, Shimane University Faculty of Medicine, 89-1, Enya-cho, Izumo, Shimane 693-8501, Japan.

المصدر: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Jul 03; Vol. 30 (7), pp. 1087-1093.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9508162 Publication Model: Print Cited Medium: Internet ISSN: 1536-4844 (Electronic) Linking ISSN: 10780998 NLM ISO Abbreviation: Inflamm Bowel Dis Subsets: MEDLINE

مواضيع طبية MeSH: Colitis, Ulcerative*/drug therapy , Tacrolimus*/administration & dosage , Tacrolimus*/therapeutic use , Immunosuppressive Agents*/administration & dosage , Immunosuppressive Agents*/therapeutic use , Remission Induction*, Humans ; Retrospective Studies ; Male ; Female ; Adult ; Middle Aged ; Severity of Illness Index ; Induction Chemotherapy ; Administration, Oral ; Treatment Outcome ; Mesalamine/administration & dosage ; Mesalamine/therapeutic use

المؤلفون: Rojas JI, Alonso R, Luetic G; Instituto de Neurociencias de Rosario, Rosario, Argentina., Patrucco L; Centro de esclerosis múltiple de Buenos Aires, CABA, Argentina., Casas M; Centro Universitario de Esclerosis Múltiple - Hospital Dr. J. M. Ramos Mejía, Facultad de Medicina - UBA, CABA, Argentina., Silva B, Miguez J; Servicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina., Deri N; Centro de Investigaciones Diabaid, CABA, Argentina., Vrech C; Departamento de Enfermedades desmielinizantes - Sanatorio Allende, Córdoba., Liwacki S, Piedrabuena R, Silva E; Predigma - Centro de Medicina Preventiva, Posadas, Misiones, Argentina., Tkachuk V; Sección de Neuroinmunología y Enfermedades Desmielinizantes, Servicio de Neurología - Hospital de Clínicas José de San Martín, CABA, Argentina., Burgos M; Servicio de Neurología - Hospital San Bernardo, Salta, Argentina., Tavolini D; INECO Neurociencias Oroño - Fundación INECO, Rosario, Santa Fe, Argentina., Zanga G; Unidad asistencial César Milstein, CABA, Argentina., Pinheiro AA; Hospital San Martín, Paraná, Entre Ríos, Argentina., Hryb J; Servicio de Neurología - Hospital Carlos G. Durand, CABA, Argentina., Leguizamon F; Hospital de Agudos, Dr. Teodoro Álvarez, CABA, Argentina., Knorre E; Hospital de Agudos, Dr. Teodoro Álvarez, CABA, Argentina., Lopez PA; Neuroimmunology Unit, Department of Neuroscience, Hospital Aleman, Buenos Aires, Argentina., Martinez A; Sección de Enfermedades Desmielinizantes - Hospital Británico, CABA, Argentina., Carrá A; Sección de Enfermedades Desmielinizantes - Hospital Británico, CABA, Argentina., Alonso Serena M; Servicio de clínica médica, Hospital Italiano de Buenos Aires, CABA, Argentina., Cristiano E; Centro de esclerosis múltiple de Buenos Aires, CABA, Argentina., Correale J; Departamento de Neurología - FLENI, CABA, Argentina., Garcea O; Centro Universitario de Esclerosis Múltiple - Hospital Dr. J. M. Ramos Mejía, Facultad de Medicina - UBA, CABA, Argentina., Fernandez Liguori N, Carnero Contentti E; Neuroimmunology Unit, Department of Neuroscience, Hospital Aleman, Buenos Aires, Argentina.

المصدر: Clinical neuropharmacology [Clin Neuropharmacol] 2024 Jul-Aug 01; Vol. 47 (4), pp. 120-127. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7607910 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-162X (Electronic) Linking ISSN: 03625664 NLM ISO Abbreviation: Clin Neuropharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Cladribine*/therapeutic use , Cladribine*/adverse effects , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/adverse effects , Registries*, Humans ; Argentina/epidemiology ; Female ; Male ; Adult ; Longitudinal Studies ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/epidemiology ; Treatment Outcome ; Lymphopenia/chemically induced ; Lymphopenia/epidemiology ; Young Adult

المؤلفون: Alhubaishi AA; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alsharekh LM; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Almoharb HF; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alqarni FA; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alqahtani AM; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alghazwni MK; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alfuraydi MA; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alsadi AZ; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Altalhi RY; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Almutairi TM; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia., Alshehri GH; From the Department of Pharmacy Practice (Alhubaishi, Alshehri), College of Pharmacy, Princess Nourah bint Abdulrahman University, from the Department of Pharmacy (Alsharekh, Almoharb, Alqarni, Alghazwni, Alfuraydi), Security Forces Hospital, from Clinical Research Department (Alqahtani), King Fahad Medical City, from the Department of Internal Medicine (Alsadi), Security Forces Hospital, Department of Neuroscience (Almutairi), King Faisal Specialist Hospital and Research Centre, Riyadh, and from Department of Internal Medicine (Altalhi), King Faisal Medical Complex, Taif, Kingdom of Saudi Arabia.

المصدر: Neurosciences (Riyadh, Saudi Arabia) [Neurosciences (Riyadh)] 2024 Jul; Vol. 29 (3), pp. 184-189.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Armed Forces Hospital Country of Publication: Saudi Arabia NLM ID: 101252453 Publication Model: Print Cited Medium: Internet ISSN: 1319-6138 (Print) Linking ISSN: 13196138 NLM ISO Abbreviation: Neurosciences (Riyadh) Subsets: MEDLINE

مواضيع طبية MeSH: Fingolimod Hydrochloride*/therapeutic use , Fingolimod Hydrochloride*/adverse effects , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/adverse effects , Patient Safety* , Multiple Sclerosis*/drug therapy, Humans ; Female ; Male ; Retrospective Studies ; Adult ; Middle Aged ; Guideline Adherence/statistics & numerical data

المؤلفون: Ma Y; Department of Pharmacy, Peking University Third Hospital, Beijing, China., Wei C; Department of Rheumatology and Immunology, Center for Rare Disease, Peking University Third Hospital, Beijing, China., Yi Z; Department of Rheumatology and Immunology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China., Song Z; Department of Pharmacy, Peking University Third Hospital, Beijing, China., Cheng Y; Department of Pharmacy, Peking University Third Hospital, Beijing, China., Zeng L; Research Centre of Clinical Epidemiology, Peking University Third Hospital, Beijing, China., Zhao R; Department of Pharmacy, Peking University Third Hospital, Beijing, China., Mu R; Department of Rheumatology and Immunology, Center for Rare Disease, Peking University Third Hospital, Beijing, China.

المصدر: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Jul; Vol. 27 (7), pp. e15251.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model: Print Cited Medium: Internet ISSN: 1756-185X (Electronic) Linking ISSN: 17561841 NLM ISO Abbreviation: Int J Rheum Dis Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19*/epidemiology , Rheumatic Diseases*/drug therapy , Rheumatic Diseases*/epidemiology , Glucocorticoids*/therapeutic use , Glucocorticoids*/adverse effects , Immunosuppressive Agents*/adverse effects , Immunosuppressive Agents*/therapeutic use , Severity of Illness Index* , SARS-CoV-2*, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Risk Factors ; Aged ; Adult ; China/epidemiology ; Case-Control Studies ; COVID-19 Vaccines/adverse effects ; Vaccination ; Time Factors ; Hospitalization/statistics & numerical data

المؤلفون: Frangou E; Department of Nephrology, Limassol General Hospital, State Health Services Organization, Limassol, Cyprus.; Department of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia, Cyprus., Anders HJ; Division of Nephrology, Department of Internal Medicine IV, Hospital of the Ludwig-Maximilians-University, Munich, Germany., Bajema IM; Department of Pathology and Medical Biology, University of Groningen, University Medical Center, Groningen, The Netherlands., Teng YKO; Center of Expertise for Lupus, Vasculitis and Complement-mediated Systemic Disease (LuVaCs), Department of Internal Medicine - Section Nephrology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands., Malvar A; Nephrology Unit, Hospital Fernandez, Buenos Aires, Argentina., Rovin BH; Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio., Kronbichler A; Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.

المصدر: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2024 Jul 01; Vol. 35 (7), pp. 955-958. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Lupus Nephritis*/drug therapy , Lupus Nephritis*/complications , Immunosuppressive Agents*/adverse effects , Immunosuppressive Agents*/therapeutic use, Humans ; Withholding Treatment